Drug · DIN 02520869
RUKOBIA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 26, 2022; first marketed April 26, 2022.
- Drug Identification Number (DIN)
- 02520869
- Company (DIN owner)
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Fostemsavir J05AX29
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FOSTEMSAVIR (FOSTEMSAVIR TROMETHAMINE) | 600 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 1, 2021: NOC 26753New Drug Submission (NDS)